Home Antibody All anti-APOA2 antibodies
Anti-APOA2 Antibody EP2912
Also for APOA2 (NM_001643)
|A synthetic peptide corresponding to residues near the N-terminus region of human Apolipoprotein A-II (ApoA-II) was used as an immunogen.|
||Tissue culture supernatant
|Human (Does not react with: Mouse, Rat)
||Lot dependent; please refer to CoA along with shipment
||WB: 1:1000 - 1:10000
|PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%|
|Is unsuitable for Flow Cyt,ICC,IHC-P or IP.
|Homo sapiens apolipoprotein A-II (APOA2)|
|Apo-AII; ApoA-II; apoAII|
Entrez Gene 336 Human
|Apolipoprotein A II is the second most abundant protein of the high density lipoprotein particles, accounting for 20% of protein mass of HDL. The concentration of ApoA-I and ApoA-II is inversely correlated with the frequency of heart disease in human (1). In studies with mice and humans, ApoA-II levels have been associated with increased susceptibility to atherosclerosis, increased free fatty acid levels, increased body fat, and increased insulin resistance (2). ApoA-II consists of three potential amphipathic helices of 17 residues each, which contribute to the lipid-binding properties of this apolipoprotein (3). Currently, the best characterized activity of apoA-II is its potent antagonism of the anti-atherogenic and anti-inflammatory activities of ApoA-I, probably due to its competition with the latter for lipid acyl side chains of HDL (1).|
|Secreted ProteinDruggable Genome PPAR signaling pathway|
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot - Anti-Apolipoprotein A II antibody [EP2912]; Anti-Apolipoprotein A II antibody [EP2912] at 1/1000 dilution + Human plasma lysate at 10 ug.Predicted band size : 11 kDa.